Showing results (1-10 of 124) with videos related to
Sort By:
Pageof 13
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2008
Simultaneous detection of anti-HCV antibody and HCV core antigenFilippo Ansaldi, Giancarlo IcardiExpert Opinion on Biological Therapy|March 12, 2010
MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at riskPaolo Durando, Giancarlo Icardi, Filippo AnsaldiExpert Opinion on Biological Therapy|February 9, 2011
Intradermal influenza vaccine and new devices: a promising chance for vaccine improvementFilippo Ansaldi, Paolo Durando, Giancarlo IcardiHuman Vaccines & Immunotherapeutics|February 2, 2012
Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection systemGiancarlo Icardi, Andrea Orsi, Antonella Ceravolo, et al.Drugs & Aging|February 1, 2011
Inactivated influenza vaccines: recent progress and implications for the elderlyValentina Parodi, Daniela de Florentiis, Mariano Martini, et al.Expert Review of Vaccines|December 14, 2011
Fluzone(®) Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adultsFilippo Ansaldi, Daniela de Florentiis, Paolo Durando, et al.Mutation Research|July 1, 2009
Interaction between Helicobacter pylori, diet, and genetic polymorphisms as related to non-cancer diseasesAlberto Izzotti, Paolo Durando, Filippo Ansaldi, et al.International Journal of Molecular Sciences|July 19, 2016
Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 VaccinationAndrea Orsi, Filippo Ansaldi, Cecilia Trucchi, et al.World Journal of Gastroenterology|August 12, 2014
Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapyFilippo Ansaldi, Andrea Orsi, Laura Sticchi, et al.Epidemiologia E Prevenzione|March 12, 2015
[Immunization campaign with 13-valent Pneumococcal Conjugate Vaccine in adults in Liguria Region, Italy: one year post-introduction preliminary results]Andrea Orsi, Filippo Ansaldi, Paolo Durando, et al.Pageof 13